Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Revue De Pneumologie Clinique|November 12, 2013
[First epidemiologic data on pneumonia in Cambodia]V Avrillon, C Ny, S Chan, et al.
Revue Des Maladies Respiratoires|January 14, 2012
[Bronchiolo-alveolar carcinoma and lung transplantation]V Avrillon, F Philit, L Chalabreysse, et al.
Revue De Pneumologie Clinique|June 26, 2013
[How practical guidelines can be applied in poor countries? Example of the introduction of a bronchoscopy unit in Cambodia]S Couraud, S Chan, V Avrillon, et al.
Revue Des Maladies Respiratoires|March 24, 2012
[Chronic necrotizing pulmonary aspergillosis following an infection by Mycobacterium malmoense]D Gomez-Abreo, C Prost, S Couraud, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 7, 2022
[Practice of French urologists concerning the checklist of the operating room]M Abdessater, P Michel, F Bardet, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 21, 2022
[Complications in urological surgery. The urologist as a player in risk management]J Irani, S Bart, V Avrillon, et al.
ESMO Open|January 4, 2025
Anti-IL-6R Ab tocilizumab to treat paraneoplastic inflammatory syndrome of solid cancersJ-Y Blay, M Brahmi, A Dufresne, et al.
ESMO Open|March 1, 2022
Lorlatinib for advanced ROS1+ non-small-cell lung cancer: results of the IFCT-1803 LORLATU studyN Girard, S Galland-Girodet, V Avrillon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2020
Vemurafenib in non-small-cell lung cancer patients with BRAF<sup>V600</sup> and BRAF<sup>nonV600</sup> mutationsJ Mazieres, C Cropet, L Montané, et al.
ESMO Open|January 30, 2021
Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancerP Heudel, S Chabaud, D Perol, et al.
Pageof 1